Stem cell innovators

Senior Researcher and Group Leader at MRC Centre for Regenerative Medicine, University of Edinburgh, UK

Dr. Tilo Kunath’s research group focuses on mechanisms of neurodegeneration with two main areas; to understand how the protein, α-synuclein, causes degeneration of neurons in Parkinson’s, and to produce a cell-based therapy for Parkinson’s from human pluripotent stem cells. The group also uses patient-derived material to generate induced pluripotent stem cells (iPSCs) with genetic mutations known to cause Parkinson’s.